Crossmark

Randomised Controlled Trial Evaluating the Impact of Intravenous Iron (ferric carboxymaltose) Supplementation Among Epithelial Ovarian Cancer Patients with Anemia

Crossref DOI link: https://doi.org/10.1007/s13193-024-02149-9

Published Online: 2024-12-02

Published Print: 2025-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Patel, Viral https://orcid.org/0000-0003-2261-767X
Rajanbabu, Anupama

Pavithran, Keechilat

Anandita, Anandita
Funding

Funding for this research was provided by:

Amrita Vishwa Vidyapeetham University (1 (Amrita academic research grant fund))
License Information

Text and Data Mining valid from 2024-12-02

Version of Record valid from 2024-12-02
More Information

Article History

Received: 6 October 2024

Accepted: 26 November 2024

First Online: 2 December 2024

Declarations

: There are no instances of plagiarism in the manuscript.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below